ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

DCT Board Says RDOG Concept Too Expensive; Discusses Grant Funding

July 24, 1992

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000